Skip to content
Screener

Pulse Biosciences, Inc. PLSE Q1 2026 Annual earnings

Reported May 4, 2026 · Before market open

Revenue$400.0KBeat by $150.0K
EPS-$0.27Beat by $0.05
Revenue estimate$250.0K
EPS estimate-$0.32

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$620.0K
EPS estimate-$0.35

Financials

Q1 2026

Income statement

See full
Revenue$401.0K—
Gross profit$31.0K—
Operating income-$19.2M-6.1%
Net income-$18.6M-10.6%

Balance sheet

See full
Cash & equivalents$68.3M-42.7%
Total debt$7.2M-16.6%
Total equity$66.3M-44.0%
Total assets$81.6M-38.8%

Cash flow

See full
Operating cash flow-$14.6M-7.9%
CapEx$33.0K-26.7%
Free cash flow-$14.6M-7.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$1.47B+38.4%
Enterprise value$1.41B+48.1%
P/S1,954.6×—

Profitability

See full
Gross margin-21.6%—
Operating margin-10,392.1%—
Net margin-9,929%—
FCF margin-7,390%—

Returns & leverage

See full
Return on equity-80.7%+3.1pp
Debt / equity0.1×0.0×
Current ratio7.3×-8.3×

FAQ

When did Pulse Biosciences, Inc. report Q1 2026 earnings?
Pulse Biosciences, Inc. (PLSE) reported Q1 2026 earnings on May 4, 2026 before market open.
What were Pulse Biosciences, Inc.'s Q1 2026 revenue and EPS?
Pulse Biosciences, Inc. reported revenue of $400.0K and eps of $-0.27 for Q1 2026.
Did Pulse Biosciences, Inc. beat estimates in Q1 2026?
Revenue beat the consensus estimate of $250.0K by $150.0K. EPS beat the consensus estimate of $-0.32 by $0.05.
How did Pulse Biosciences, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 58.8% from $-0.17.
Where can I find Pulse Biosciences, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001437749-26-014547) and the 10-K/A periodic report (0001437749-26-014203) directly on SEC EDGAR. The filing index links above go to sec.gov.